112 related articles for article (PubMed ID: 20482314)
1. Tissue kallikrein promotes prostate cancer cell migration and invasion via a protease-activated receptor-1-dependent signaling pathway.
Gao L; Smith RS; Chen LM; Chai KX; Chao L; Chao J
Biol Chem; 2010 Jul; 391(7):803-12. PubMed ID: 20482314
[TBL] [Abstract][Full Text] [Related]
2. A novel signaling pathway of tissue kallikrein in promoting keratinocyte migration: activation of proteinase-activated receptor 1 and epidermal growth factor receptor.
Gao L; Chao L; Chao J
Exp Cell Res; 2010 Feb; 316(3):376-89. PubMed ID: 19879874
[TBL] [Abstract][Full Text] [Related]
3. Prostate-specific kallikreins-2 and -4 enhance the proliferation of DU-145 prostate cancer cells through protease-activated receptors-1 and -2.
Mize GJ; Wang W; Takayama TK
Mol Cancer Res; 2008 Jun; 6(6):1043-51. PubMed ID: 18567807
[TBL] [Abstract][Full Text] [Related]
4. Tissue kallikrein mediates neurite outgrowth through epidermal growth factor receptor and flotillin-2 pathway in vitro.
Lu Z; Cui M; Zhao H; Wang T; Shen Y; Dong Q
Cell Signal; 2014 Feb; 26(2):220-32. PubMed ID: 24211626
[TBL] [Abstract][Full Text] [Related]
5. Differential roles of ERK and Akt pathways in regulation of EGFR-mediated signaling and motility in prostate cancer cells.
Gan Y; Shi C; Inge L; Hibner M; Balducci J; Huang Y
Oncogene; 2010 Sep; 29(35):4947-58. PubMed ID: 20562913
[TBL] [Abstract][Full Text] [Related]
6. Activation of proteinase-activated receptor 1 promotes human colon cancer cell proliferation through epidermal growth factor receptor transactivation.
Darmoul D; Gratio V; Devaud H; Peiretti F; Laburthe M
Mol Cancer Res; 2004 Sep; 2(9):514-22. PubMed ID: 15383630
[TBL] [Abstract][Full Text] [Related]
7. Thrombin-mediated hepatocellular carcinoma cell migration: cooperative action via proteinase-activated receptors 1 and 4.
Kaufmann R; Rahn S; Pollrich K; Hertel J; Dittmar Y; Hommann M; Henklein P; Biskup C; Westermann M; Hollenberg MD; Settmacher U
J Cell Physiol; 2007 Jun; 211(3):699-707. PubMed ID: 17323377
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of tissue factor/protease-activated receptor-2 signaling limits proliferation, migration and invasion of malignant glioma cells.
Gessler F; Voss V; Dützmann S; Seifert V; Gerlach R; Kögel D
Neuroscience; 2010 Feb; 165(4):1312-22. PubMed ID: 19958818
[TBL] [Abstract][Full Text] [Related]
9. Mitogenic signalling by B2 bradykinin receptor in epithelial breast cells.
Greco S; Muscella A; Elia MG; Romano S; Storelli C; Marsigliante S
J Cell Physiol; 2004 Oct; 201(1):84-96. PubMed ID: 15281091
[TBL] [Abstract][Full Text] [Related]
10. Bradykinin receptor subtype 1 expression and function in prostate cancer.
Taub JS; Guo R; Leeb-Lundberg LM; Madden JF; Daaka Y
Cancer Res; 2003 May; 63(9):2037-41. PubMed ID: 12727816
[TBL] [Abstract][Full Text] [Related]
11. Coagulation factor Xa inhibits cancer cell migration via protease-activated receptor-1 activation.
Borensztajn K; Bijlsma MF; Reitsma PH; Peppelenbosch MP; Spek CA
Thromb Res; 2009 Jun; 124(2):219-25. PubMed ID: 19250659
[TBL] [Abstract][Full Text] [Related]
12. Thrombin enhanced migration and MMPs expression of human chondrosarcoma cells involves PAR receptor signaling pathway.
Chen HT; Tsou HK; Tsai CH; Kuo CC; Chiang YK; Chang CH; Fong YC; Tang CH
J Cell Physiol; 2010 Jun; 223(3):737-45. PubMed ID: 20175118
[TBL] [Abstract][Full Text] [Related]
13. Mechanisms for prostaglandin E2 formation caused by proteinase-activated receptor-1 activation in rat gastric mucosal epithelial cells.
Sekiguchi F; Saito S; Takaoka K; Hayashi H; Nagataki M; Nagasawa K; Nishikawa H; Matsui H; Kawabata A
Biochem Pharmacol; 2007 Jan; 73(1):103-14. PubMed ID: 17069767
[TBL] [Abstract][Full Text] [Related]
14. Gonadotropin-releasing hormone promotes ovarian cancer cell invasiveness through c-Jun NH2-terminal kinase-mediated activation of matrix metalloproteinase (MMP)-2 and MMP-9.
Cheung LW; Leung PC; Wong AS
Cancer Res; 2006 Nov; 66(22):10902-10. PubMed ID: 17108127
[TBL] [Abstract][Full Text] [Related]
15. Protease-activated receptor-2 is essential for factor VIIa and Xa-induced signaling, migration, and invasion of breast cancer cells.
Morris DR; Ding Y; Ricks TK; Gullapalli A; Wolfe BL; Trejo J
Cancer Res; 2006 Jan; 66(1):307-14. PubMed ID: 16397244
[TBL] [Abstract][Full Text] [Related]
16. Prostaglandin E2 activates mitogen-activated protein kinase/Erk pathway signaling and cell proliferation in non-small cell lung cancer cells in an epidermal growth factor receptor-independent manner.
Krysan K; Reckamp KL; Dalwadi H; Sharma S; Rozengurt E; Dohadwala M; Dubinett SM
Cancer Res; 2005 Jul; 65(14):6275-81. PubMed ID: 16024629
[TBL] [Abstract][Full Text] [Related]
17. Signal transduction for proteinase-activated receptor-2-triggered prostaglandin E2 formation in human lung epithelial cells.
Kawao N; Nagataki M; Nagasawa K; Kubo S; Cushing K; Wada T; Sekiguchi F; Ichida S; Hollenberg MD; MacNaughton WK; Nishikawa H; Kawabata A
J Pharmacol Exp Ther; 2005 Nov; 315(2):576-89. PubMed ID: 16120814
[TBL] [Abstract][Full Text] [Related]
18. Protein C and its inhibitor in malignancy.
Suzuki K; Hayashi T
Semin Thromb Hemost; 2007 Oct; 33(7):667-72. PubMed ID: 18000793
[TBL] [Abstract][Full Text] [Related]
19. Neurotensin stimulates mitogenesis of prostate cancer cells through a novel c-Src/Stat5b pathway.
Amorino GP; Deeble PD; Parsons SJ
Oncogene; 2007 Feb; 26(5):745-56. PubMed ID: 16862179
[TBL] [Abstract][Full Text] [Related]
20. A role for phospholipase C-gamma-mediated signaling in tumor cell invasion.
Kassis J; Moellinger J; Lo H; Greenberg NM; Kim HG; Wells A
Clin Cancer Res; 1999 Aug; 5(8):2251-60. PubMed ID: 10473113
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
